This inventor holds 1 USPTO granted patent. Top assignee: Mogam Biotechnology Institute. Active years: 2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2000
Title: **Changwon Park: Innovator in Immunosuppressive Agents**
Introduction
Changwon Park is a noted inventor based in Kyonggi-do, South Korea. He has made significant contributions to the field of immunology through his innovative research and patents.
Latest Patents
Changwon Park holds a patent titled "Use of rosmarinic acid and derivatives thereof as an immunosuppressant." This patent presents a groundbreaking approach wherein rosmarinic acid and its derivatives are utilized as immunosuppressive agents. The invention details how these compounds specifically inhibit the binding of ligand peptides to the Lck SH2 domain, consequently disturbing the Lck-mediated signal transduction in T cells. Furthermore, it highlights the ability of rosmarinic acid to inhibit cytokine gene expression and suppress immune responses in transplanted tissues. These findings underline the potential applicability of these compounds for treating, preventing, and diagnosing graft rejection, graft-versus-host disease (GVHD), autoimmune diseases, and various inflammatory conditions.
Career Highlights
Changwon Park is affiliated with the Mogam Biotechnology Research Institute, where he has been actively involved in research focused on immunology and related fields. His work—especially the patented use of rosmarinic acid—represents a significant advancement in therapies aimed at modulation of immune responses.
Collaborations
Throughout his career, Changwon Park has collaborated with esteemed colleagues, including Eun Mi Hur and Young Bong Choi. These partnerships have enhanced his research endeavors and contributed to the successful development of innovative solutions within the realm of biotechnology.
Conclusion
In summary, Changwon Park is a distinguished inventor whose work with rosmarinic acid and its derivatives has paved the way for potential advancements in immunosuppressive therapies. His contributions, rooted in innovative research, are critical in addressing significant medical challenges associated with immune responses.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile